[How to improve patients and investigators' information on clinical trials: the example of French registry for clinical trials in oncology].
Cancer patients' willingness to be informed about clinical trials (CT) is rapidly increasing. Health professionals are also interested on being informed on CT in order to provide their patients the best access to innovative treatments. The French cancer plan (2003-2007) launched the creation of a national registry for clinical trials in oncology. The primary objective was to guarantee patients and investigators comprehensive, high quality and updated information about ongoing CT in France, accessed at www.e-cancer.fr. A second objective was to establish a single channel for registration of French CT in conformity with the requirements of the International Committee of Medical Journal Editors. A unique Web access for patients and investigators was created. Information important for patients is presented in the first pages. Scientific information is accessible under further clicks. An information page about clinical research, intended for patients and their relatives, was also prepared in collaboration with patients' advocacy and healthcare professionals. Achieving comprehensiveness is one of the founding principles of the RECF. Over 600 CT were registered as of end of July 2008. All French academic sponsors have registered their CT; the publication of the industrial trials has begun in early 2008.
Pauporté
Iris
I
Institut national du cancer, Boulogne-Billancourt, France. ipauporte@institutcancer.fr
Manach
E
E
Bachouche
N
N
Hommais
A
A
Détry
S
S
Legrand-Lane
C
C
Barbare
J-C
JC
D035843:Biomedical Research; D002986:Clinical Trials as Topic; D005602:France; D006801:Humans; D020407:Internet; D009369:Neoplasms / Q000628:therapy*; D010353:Patient Education as Topic; D012042:Registries; D012108:Research Personnel